ABOS

Acumen Pharmaceuticals Inc (ABOS)

US
$ 1.45-0.68%

Price Chart

Key Statistics

Market Cap
$ 73.9M
P/E Ratio
0.00
Revenue (TTM)
$ 329K
Volume
161.34K
52W High
$ 3.60
52W Low
$ 0.85
Dividend Yield
0.00%
Beta
0.05

Technicals

50-Day MA
1.0613
200-Day MA
1.7482
52 Week High
3.6
52 Week Low
0.855

About ABOS

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.

Employees
61
Headquarters
Newton, MA
CEO
Mr. Daniel J. O'Connell M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg